Key Points
- Dolby SVP John Couling sold 7,666 shares of company stock on June 1 at an average price of $55.62, totaling about $426,383. After the sale, he still held 118,727 shares valued at roughly $6.6 million.
- Dolby recently reported better-than-expected quarterly results, with earnings per share of $1.37 and revenue of $395.63 million, both above analyst estimates. Revenue also rose 7% year over year.
- The company continues to pay a dividend and has a mixed but generally positive analyst outlook. Dolby paid a quarterly dividend of $0.36 per share, and the stock currently carries a consensus rating of “Moderate Buy” with a target price of $90.75.
Dolby Laboratories (NYSE:DLB - Get Free Report) SVP John Couling sold 7,666 shares of Dolby Laboratories stock in a transaction on Monday, June 1st. The shares were sold at an average price of $55.62, for a total transaction of $426,382.92. Following the completion of the transaction, the senior vice president directly owned 118,727 shares of the company's stock, valued at $6,603,595.74. The trade was a 6.07% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Dolby Laboratories Stock Performance
DLB opened at $54.91 on Thursday. Dolby Laboratories has a fifty-two week low of $52.45 and a fifty-two week high of $77.00. The company has a fifty day moving average of $59.16 and a two-hundred day moving average of $62.78. The stock has a market capitalization of $5.19 billion, a price-to-earnings ratio of 21.70 and a beta of 0.81.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts' consensus estimates of $1.31 by $0.06. The business had revenue of $395.63 million during the quarter, compared to analysts' expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business's revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. On average, equities research analysts forecast that Dolby Laboratories will post 3.21 earnings per share for the current year.
Dolby Laboratories Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.6%. Dolby Laboratories's payout ratio is 56.92%.
Analyst Ratings Changes
DLB has been the subject of a number of research reports. Wall Street Zen raised shares of Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Saturday, May 30th. Weiss Ratings reissued a "hold (c-)" rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Finally, Barrington Research reissued an "outperform" rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, April 27th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $90.75.
Read Our Latest Analysis on DLB
Institutional Trading of Dolby Laboratories
Several large investors have recently made changes to their positions in DLB. Norges Bank purchased a new stake in shares of Dolby Laboratories during the fourth quarter worth approximately $54,966,000. AQR Capital Management LLC increased its position in shares of Dolby Laboratories by 51.8% during the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker's stock worth $128,935,000 after purchasing an additional 592,282 shares in the last quarter. First Trust Advisors LP raised its holdings in Dolby Laboratories by 19.9% in the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker's stock valued at $135,431,000 after acquiring an additional 374,405 shares during the last quarter. Alyeska Investment Group L.P. acquired a new stake in Dolby Laboratories in the 4th quarter valued at about $23,477,000. Finally, Voloridge Investment Management LLC raised its holdings in Dolby Laboratories by 2,017.9% in the 4th quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker's stock valued at $20,904,000 after acquiring an additional 310,130 shares during the last quarter. 58.56% of the stock is currently owned by hedge funds and other institutional investors.
Dolby Laboratories Company Profile
(
Get Free Report)
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
